Featured

Recently, Ravi Parikh, MD, MPP, an Assistant Professor of Medical Ethics and Health Policy and Medicine at the University of Pennsylvania, Perelman School of Medicine, released a research letter titled, "Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval." In this interview with OncData, he further discusses his research and gives a thought-provoking analysis of what these findings could mean for the future of the accelerated approval program, as well as how the multidisciplinary team could better advocate and let their voices ...

From the Editor's Desk

I am thrilled to announce that I will be staying on as Editor in Chief of Oncology Data Advisor for at least another year. It gives me such great joy to work with such an accomplished group of experts in oncology, as well as with an extremely professional core of editors headed up by Keira Smith. We have grand plans for 2023. In the meantime, please avail yourselves of some of the best commentary in oncology today. I want to especially recommend two of our offerings that have recently hit the we...



Copyright © Oncology Data Advisor. All rights reserved.